跨性别男性在妇科肿瘤诊疗中的临床需求
本文综述跨性别男性在妇科肿瘤诊疗中的障碍与临床需求。该人群仍面临妇科恶性肿瘤风险,却因歧视和健康差异而服务不足。文章建议加强医护人员教育培训、理解筛查障碍,并呼吁开展针对该人群的筛查与癌症监测研究。
要点
- 跨性别男性仍面临妇科恶性肿瘤风险,属于服务不足人群。
- 歧视与健康差异影响其在妇科和肿瘤科的诊疗体验。
- 需加强医护人员教育并开展筛查与监测研究以减少差异。
核心结论
- 跨性别男性在妇科肿瘤诊疗中存在未被满足的临床需求,需通过教育、培训和研究改善照护。
研究设计与样本
- 本文为综述,聚焦跨性别男性在妇科肿瘤诊疗中的障碍与临床需求,并提出改进建议。
主要发现
- 跨性别男性仍面临妇科恶性肿瘤风险,但属于服务不足人群。
- 跨性别群体经历歧视,并存在导致妇科和肿瘤科健康差异的经历。
- 美国虽已努力减少该群体的不平等,但临床环境中仍有许多需求未满足。
临床怎么用
- 加强医护人员教育与培训,增进对健康筛查和资源利用障碍的理解,可能减少部分差异。
- 需开展针对该群体的筛查与癌症监测研究,以了解潜在额外风险和生存差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Transgender men remain at risk for gynecologic malignancies, but are an underserved population. Members of the transgender community experience discrimination and have experiences that contribute to health disparities, including in gynecology and oncology. While efforts have been made within the United States to reduce inequalities experienced by members of this community, many needs in the clinical setting remain. Increased education and training among providers and healthcare professionals, and general improvements towards understanding barriers to health screening and health resource uptake may reduce some disparities. Additional research towards screening and cancer surveillance among this community will be necessary to understand any potential additional risks and survival disparities experienced by transgender men. This review focuses on barriers and clinical needs for transgender men in the gynecologic oncology setting, and suggestions for moving forward to improve care for this patient population.
引用
- Stenzel AE, Moysich KB, Ferrando CA, et al. Clinical needs for transgender men in the gynecologic oncology setting. Gynecol Oncol. 2020. PMID: 33004214. doi:10.1016/j.ygyno.2020.09.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。